"Non multum sed multa et nos mutamur" Enfermedad de Alzheimer: entidad de interacciones multimoleculares complejas
Contenido principal del artículo
Resumen
Resistir la vejez es nuestra obligación, para compensar sus defectos. Luchar contra ella como luchamos contra las enfermedades. Mucha mayor atención se le debe a la mente y al alma porque ellas, como las lámparas, disminuyen su luz con el tiempo a menos que las sigamos alimentando con aceite. La actividad intelectual alimenta y eleva la mente. El viejo retiene sus facultades mentales si su interés y dedicación continúan.
Detalles del artículo
Cómo citar
Referencias
Lowe J, Spillentini MG. Non-Alzheimer degenerative disorders. Brain Pathol 1998; 8: 295-298.
Alzheimer A. A characteristic disease of the cerebral cortex. In: Thc carly story of Alzheimer's disease. Bick K, Amaducci L. Pepeu G eds. Padun, Liviana 1986.
Schmidt ML. Lee VM-Y, Forman M, Chiu TS, Trojanowski JQ. Monoclonal untibodies to a 100-kd protein revea! abundan! A~ plaques
rhroughout gray matter of Alzheimer's disease brains. Am J Pathol 1997;
: 69-80.
Castañeda M. Envejecimiento: La última aventura. Fondo de Cul•
tura Económica. México, DF. 1994.
Einstein G. Buranosky R. Crain BJ. Dendrilic pathology of granule cells in AD is unrelated lo neuritic plaques. J Neusci 1994; 14: 5077-5088.
McKhann G. Drachman D, Folstein M, Katzman R. Price D. Sta• dlan EM. Clínica! diagnosis of Alzheirners disease, Rcport ofthe NINC• DS-ADRDA work group under the auspíces of the Departrnent of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
Folstein M. Folslein SE, McHugh PR. «Mini-Mental State»: A practica! method for grading thc cognilivc state of patients for the clinician. J Psychiatry Res 1975; 12: 189-198.
Hughcs C, Berg L. Danziger L. Cohen LA, Martín RL. A new clinical rating scale for staging dementia. Br J Psychiatry 1982; 140: 566-572.
Helkala E-L. Laulumaa V, Soininen H. Rickkinen PJ. Recall and recognition on memory in patients with Alzheimer's and Parkinson's di• seascs. Ann Neurol 1988; 24: 214-217.
Millber WP, Hebben N. Kaplan E. The Bosron process approach to ncuropsychological assesment. In: Grant 1, Adams KM eds, Neuropsycholugical Asscsment of Neuropsychiatric Disorders. New York. Oxford Univcrsity Press, 1986: 65-86.
Russell EW. A rnultiple scoring method for the assesrnent of cnmplex memory functions. J Cons Clin Psychology 1975; 43: 800-809.
Maguire EA, Burgess N, Donnell JG, Frackowiak RSJ, Frith CD. O' Kecfe J. Knowing where and geuing there: A human navigarion network. Science 1998; 280: 921-924.
Squire LR. Zola-Morgan S. The medial temporal lobe memory system. Science 1991: 253: 1380-1386.
Juottonen K. Laakso MP, lnsausti R. Lentovirta R. Pitkanen A, Pastanen K. Volumes of the entorhinal and perirhinal cornees in Alzheimer' s disease, Neurobiol Aging 1998; 19: 1522 y 23-31.
Reiman EM, Caselli RJ, Yun LS. Preclinicul evidence of Alheimcr's disease in persons homozygous for the épsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-758.
Cordcr EH, Saunders AM, Risch NJ. Protective effect of apolipoprotein E typc 2 allcle for late onset AD. Nature Genct 1994: 7: 180-184.
Koshy B, Malilla T, Burright EN. Spinocerebelar ataxia type 1 and spinobulbar atrophy gene products interact with glyceraldehide-3- phosphate dehydrogenase. Hum Mol Genet 1996; 5: 1311-JJ 18.
Manin W. Muller M. The hydrogen hypothesis for the first eukaryote. Nature 1998; 392: 37-41.
Larsson N-G. Wang J. Wilhemsson H, Oldfors A, Rustin P. Lcwandosky M. Mitochondrial transcription factor A is necessary for mtDNA muintenance and embryogencsis in mice. Nuture Genet 1998; l!I: Bl-236.
Miyata M. Srnith JO. Apolipoprotein E ullele-specific antioxidant activity and effects on citotoxicity by oxidative insults and beta amyloid peptides. Narure Genet 1996: 14: 55-61.
Hotcomb L, Gordon MN, McGowan E. Yu X. Benkovic S. Jantzen P. Accelerated Alzheuner-type phenorype in trnnsgenic mice carrying hoth mutan! amyloid and presenilin Irransgenes. Nature Med
!1; ~: 97-100.
Poorkaj P. Bird TD. Wijsman E. Nernens E. Garrulo MR. Anderson L. Tau is a candidate gene for chrornosorne 17 Irontoternporal demenua, Ann Neurol 1998: 43: 815-ij25. Y Proc Natl Acad Sci 1998; 95:77~7-7741.
Nicoll JAR, Burnen C. Love S. Graham DT. High frequency of lipoproiein E epsilon 2 allele in hernorrhage due lo cerebral amyloid angiopathy, Ann Ncurol 1997; 41: 716-721.
Pcricnck-Vance MA. Bass MP, Yamaoku LH, Gaskell PC, Roses AD. Haines JL. Complete gcnomic screen in lute-onset familia! AO. Evidencc of a ncw locus on chrornosome 12. JAMA 1997; 278: 1237-1241.
Monroya SE, Aston CE, DeKosky ST, Kamboh MI, Ferre! RE. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nature Gener 1998; 18:211-212.
Xu H, Sweeny D, Wang R, Thinakaran G, Lo ACY, Sisodia SS, Greengard P. Gandy S. Generation of Alzheimer beta amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci 1997; 94; 3748-3752.
Castaño EM, Prelli F, Soto C, Beanis R, Matsubara E, Shoji M. The length of amyloid beta in hereditary cerebral hemorrhage wíth amyloidosis, Durch type. J Biol Chem 1996; 271: 3218532191.
Goldsmith HS. Ornc:ntal transposition to the brain for Ab...eimer's disease. Ann NY Acad Sci 1997; 826: 323-336.
Van Leeuwen, de Kleiin DPV, van der Hurk HH, Neubauer A, Sonnemans MAF, Slvijs JA. Frameshift mutants of beta amyloid precursor protein and ubiquitín-B in Alzheimer's and Down patients. Science 1998; 279: 242-247.
Hullon M, Hardy D. The presenilins and Alzheimer's disease. Hum Mol Gene! 1997; 6: 1639-1646.
Xu H, Goras GK, Greenfield JP, Vincent S, Naslund J, Mazzare• lli L. Estrogen reduces neuronal generation of Alzheimer beta amyloid peptides. Nature Med 1998; 4: 447-451.
Nochlin D. Bird TD. Nemens EJ, Ball MJ, Sumí SM. Amyloíd angiopathy in a Volgan German family with Alzheimer's disease anda presenilin 2 mutalion. Ann Neurol 1998; 43: 131-135.
Crook R, Verkkoniemi A, Pérez-Tur J, Mehla N. Baker M, Houl• den H. A varianl of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med 1998; 4: 452-455.
Schachter F. Faure-Delane JL. Guenol F, Rouger H, Cohen D. Genetic associations wi1h human longevity al the APOE and ACE loci. Nature Genel 1994; 6: 29-32.
Muros M, Rodríguez-Ferrer C. Apo E polimorphism influence on lipids, apolipoproteins in a Spanish population underexpressing ApoE4. Atherosclerosis 1996; 121: 13-21.
Helisalmi S, Linnaranta K, Lehtovirta M. Apolipoprotein E poli• morphism in patients with dífferent neurodegenerative disortlers. Neu• rosci Lett 1996; 205: 61-64.
Gurman CR, Strittmater WJ, Weisgraber KH, Mathew WY. Apo• lipoprotein E binds to and potentíates the biologícal activity of ciliary neurotrophic factor. J Neurosci 1997; 17: 6114-6121.
Bullido MJ. Artiga MJ, Recuero M, Sastre l. A polymorphism in the regulatory region of APOE associated with risk of Alzheimer's de• mentia. Nature Genet 1998; 18: 69-71.
Pericack-Vance MS. Johnson CC. Rimmler JB. Alzheimer's disease apolipoprotcin 4 allelc in an Amish population. Ann Ncurol 1996:39: 700-704.
Mak YT. Chiu H, Woo J, Kay R. Chan YS. Hui E. Apolipopro1ein E genotype and Alzhcimcr's discase in Hong Kong elderly Chinese. Neurology 1996; 46: 146-149.
Rosenberger RN, Richter RW, Risser RC. Taubman K. Pra• do-Farmer 1, Ebalo E. Genetic factors for the development of Alzheier's disease in the Cheroque ltidian. Arch Neurol 1996; 53: 997-1000.
Tang M-X, Stern Y, Marder K, Bell K. Gurland B. Lantigua R. The APOE4 allcle and the risk of Alzheimer's disease among African Americruis, Whites, and Hispanics. JAMA J 998; 279: 751-755.
Mackenzie IRA. Milles LA. Senile plaques in temporal Jobe epilepsy. Acta Neuropathol 1994; 87: 504-510.
Gouras GK, Relkin NR. Sweeney D, Muñoz DG, Mackenzie IR. Gandy S. lncrcased Apo E4 in epilepsy with senile plaques. Ann Neurol 1997; 41: 402-404.
Roberts GW. Allsop D, Bruton CJ. The occult aftermath oí boxing. Neurol Neurosurg Psych 1990; 53: 373-378.
Nicoll JAR. Roberts GW. Graham DS. Apolipoprotein E4 allele is associated with deposition oí amyloid beta protein following head in• jury. Naturc Med 1995; 1: D5-137.
Sheng JG, lto K. Skinner RD, Mrak RE. Rovnaghi CR, Van El• dick LJ. 111 l'iw, and i11 vi/ro evidence supporting a role for the infla1mna• tory cytokine intcrleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 1996: 17: 761-766
Río Hortega P. M icro glia. In: Cytology and Cellular Pathology of the Nerv ous Systern, Penfield W ed. New York, Hocker 1932: 481-584.
Giulian D, Haverkamp LJ, Yu JH. Karshin W, Tom D. Li J. Specific domains of beta amyloid from Alzheimer plaque elicit neuron killing in human rnicroglia. J Neurosci 1996; 16: 6021-6037.
Buttini M, Westland CE, Masliah E, Yafeh AM, Wyss-Coray T. Mucke L. Novel role of human CD4 molecule idcnlified in neurodegene• ration. Nature Med 1998; 4: 441-446.
McGeer PL, Schulzer M. McGeer EG. Arthrilis and antiinflarn• rnatory agents as possible prorective factors for Alzheimer's disease: a review of 17 epidemiological studies, Neurology 1996; 47: 425-432.
Payami H, Schellenberg GD, Zareparsi S. Kaye J, Sexron GJ. Head MA. Evidence for association of HLA-A2 allele with onset age of Alzheirner's disease. Neurology 1997; 49: 512-518.
Currant M, Middleron D, Edwardson J. Perry R, McKei1h l. Mo• rris C. HLA-DR antigens associated with major genetic risk for late-on• set Alzhaimer's disease. Neuroreport 1997; 8: 14671469.
Oka A. Takashirna S. Induction of ciclooxigenase 2 in brains of patíents with Dow's syndrome and demcntia oí Alzheimer type: specific localization in affected ne uro ns and axons. Neurorcporl 1997; 5: I 1611-11614.
Frautschy SA. Yang F. Irrizarry M. Hyman B. Saido TC, Hsiao K. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 1998: 152: 307-317.
Balin BJ. Gcrard HC, Arking EJ. Appelt DM, Branigun PJ, Abrarns JT. ldentification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbio) Irnrnunol 1998; 187: 23-42.
Lindhal B, Lindhal U. Amyloid-spccific heparan sulfate from human liver and spleen. J Biol Chern 1997; 272: 26091-26094.
Geula C, Wu C-K. Saroff D. Lorenzo A, Yuan M, Yankncr BA. Aging renders the brain vulnerable 1O A~-protein neurotoxicity. Nature Med 1998; 4: 827-831.
Blacker D, Wilcox MA, Laird MN, Redes L. Horvnih SM. Go RCP. Alpha-2 macroglobulin is genctically associated with Alzheimer disease, Nature Gene! 1998; 19: 357-360.
Kang DE, Saito T, Chen X, Xia Y, Maslia E, Hansen LA. Gene• tic association of the low-density lipoprotcin rcceptor-rclated protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheirner's disease. Neurology 1997: 49: 56-61.
Rogaeva E, Piemkumar S, Song Y. Sorbí S. Brindle N, Paterson A. Evidence for an Alzheimer's discase suscepribility locus on chromosome 12 and for further locus heterogeneily. JAMA 1998: 280: 614-618. Y 619-622